BCDA
Biocardia IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$10.86M
P/E Ratio
—
EPS
$-0.85
Beta
0.55
52W High
$2.45
52W Low
$0.84
50-Day MA
$1.14
200-Day MA
$1.36
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Biocardia Inc
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.67M |
| EBITDA | $-7.80M |
| Operating Margin | 0.00% |
| Return on Equity | -950.00% |
| Return on Assets | -252.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.10 |
| Price-to-Book | 12.35 |
| Price-to-Sales (TTM) | 2520.59 |
| EV/Revenue | 23.81 |
| EV/EBITDA | -3.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $11.37M |
| Float | $8.66M |
| % Insiders | 30.04% |
| % Institutions | 7.13% |
Historical Volatility
HV 10-Day
84.78%
HV 20-Day
64.53%
HV 30-Day
57.30%
HV 60-Day
53.51%
HV Rank
27.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($15.50 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026